FDA Inspection 698518 — Medicap Laboratories

Medicap Laboratories — FEI 3006370451

The FDA completed an inspection of Medicap Laboratories on Nov 18, 2010 in Etobicoke. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Nov 18, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Etobicoke (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.